EU Drug Addiction Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: Europe
  • Country: Other
  • Report ID : 5008

  • Format: PPT, PDF

EU Drug Addiction Market Analysis: Segmented by Drug Type, Treatment, End-User- Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5008 Categories: ,

Report Description of the EU Drug Addiction Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for EU Drug Addiction Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Drug Addiction Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Drug Addiction Market Analysis Executive Summary

Europe is confronted with a rapidly evolving drug market. The increased potency and purity of illicit drugs, the record numbers of seizures and increased production in the EU, all indicate that the availability of illicit substances is growing. We also see a dramatic increase in the number of new, and often highly potent, synthetic substances present on the market.

Market Size and Key Findings

The EU Drug Addiction Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The EU drug market was conservatively estimated to be worth about EUR 30 billion in 2017. Cannabis accounts for about two fifths of this total (39 %), cocaine (31 %), heroin (25 %) and amphetamines and MDMA (5 %).

Market Dynamics

Market Growth Drivers Analysis

The drug market is a major source of income for organised crime groups (OCGs) in the EU, with minimum estimated retail value of EUR 30 billion per year. In addition to the economic impact, drug-related deaths and other harms to public health, there are broader consequences of drug markets, such as links with wider criminal activities and terrorism; the negative impact on the legal economy; violence in communities; damage to the environment; and the increasingly important issue of how the drug market can fuel corruption and undermine governance. The drug market is becoming more globally connected and technologically enabled. The main drivers of change behind the developments and new threats detailed in this report stem from the ability of OCGs to exploit the opportunities arising from the existence of global commercial markets and the associated logistical developments and digitalisation.

Market Restraints

Drug market-related violence and intimidation is a growing concern in the EU. Some new models of supply have emerged that are associated with high levels of violence and exploitation. There is no systematic assessment of violent crime associated with the operation of the drug market. However, new data on drug-related homicides suggest it is a significant phenomenon in some countries and more likely to involve the use of firearms than other types of homicide. The violence and intimidation associated with the drug markets spills over and affects families and neighborhoods as well as the individuals directly involved. The illegal financial flows have impacts on the legal economy in many ways, such as when businesses and high-value assets are acquired to launder cash.

COVID-19 impact on “EU Drug Addiction Market Analysis” 

The ongoing COVID-19 pandemic is likely to have an impact on the lives of people who use drugs and on the services responding to their needs owing to both restrictive measures introduced to mitigate the spread of the virus and any accompanying economic downturn (Costa Storti et al., 2021). In 2020, the gross domestic product of the EU fell by 7.4 % and a further negative impact on EU economies is expected in 2021. It has been suggested that the most vulnerable will suffer disproportionately from the COVID-19 economic recession (OECD, 2020).

Competitive Landscape

Key Players

Key participants include Pfizer, Indivior, Novartis, Alkermes, Cipla, Mylan, Dr. Reddy\’s Laboratorie, Glenmark, PLIVA (Odyssey), and Teva Pharmaceutical, among others.

In November 2018, Sandoz, a mentionable market player, along with Pear Therapeutics had announced the launch of reSET®, which focuses on the treatment of patients with Substance Use Disorder. It is the only and the first FDA-authorized prescription digital therapeutics for treating the condition. Thus, such initiatives by market players are not only contributing to increasing the market share of these companies, but it also helps in boosting the overall market growth.

Products in Pipeline

The main source countries, where new psychoactive substances – (NPS) are sold openly by chemical and pharmaceutical companies, are China and, to a lesser extent but particularly for those sold as medicines, India. However, a small number of illicit laboratories have also been detected in EU countries, such as the Netherlands and Poland, usually producing synthetic cathinones. Interactions between the NPS market and the market in established controlled drugs have become stronger, with NPS increasingly sold alongside illicit substances or in mixtures with them. Overlaps also exist with the market for fake medicines.

Notable Recent Deals

  • Pfizer, one of the mentionable market players, has been working in collaboration with Eli Lilly and Co. for developing non-opioid chronic pain medication called tanezumab. On 13th June 2017, this collaboration got a major boost when the drug won “fast-track” designation from the Food and Drug Administration for treating chronic back pain and osteoarthritis. Such initiatives by the market would not only positively impact their market position, but it would boost the overall growth of the market.
  • In October 2017, Maryland Addiction Recovery Center of Towson and Caron Treatment Centers made an announcement about the commencement of a new joint venture between the enterprises and the purchase of Encore Recovery Solutions based in Arlington, Virginia.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

A number of themes that have important implications for EU policies and actions recur across the analysis presented in this report. The contemporary drug market is increasingly complex, adaptive and dynamic; it is also more global in nature and more interlinked than in the past. EU policies and responses need to be equally agile, adaptive and joined-up if they are to effectively address current and future challenges in this area. In addition to operational activities, it is important that full use is made of the range of policy tools available: these include coordination mechanisms and strategies, bilateral engagement with third countries and industry, and the use of legislative and financial instruments.

1. Report Description of the EU Drug Addiction Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. EU Drug Addiction Market Analysis Executive Summary
2.1 EU Drug Addiction Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of EU Drug Addiction Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 The drug market is a major source of income for organised crime groups (OCGs) in the EU
3.1.2 Globalisation
3.1.3 Technology and Innovation
3.2 Market Restraints Analysis
3.2.1 Wider criminal activity and terrorism
3.2.2 Societal Impact
3.2.3 Impact on the legal economy
3.3 Covid-19 Market Impact Analysis
4. EU Drug Addiction Market Segmentation
4.1 By Drug Type:
4.1.1 Tobacco/Nicotine and Vaping
4.1.2 Alcohol
4.1.3 Marijuana
4.1.4 Synthetic Cannabinoids
4.1.5 Over-the-Counter Medications
4.2 By Treatment:
4.2.1 Detoxification
4.2.2 Rehabilitation Programs
4.2.3 Counseling and behavioral therapies
4.2.4 Self-help groups
4.2.5 Medications
4.3 By End-User:
4.3.1 Hospital and Clinics
4.3.2 Residential treatment centers (non-hospital)
4.3.3 Others
5. EU Drug Addiction Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Drug addiction Market
6.4 Notable recent deals in Drug addiction Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Indivior Company overview
Product & Services, Strategies & Financials
7.2 Novartis International Company overview
Product & Services, Strategies & Financials
7.3 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.4 Alkermes Company overview
Product & Services, Strategies & Financials
7.5 Cipla Company overview
Product & Services, Strategies & Financials
7.6 Mylan Company overview
Product & Services, Strategies & Financials
7.7 Glenmark Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Drug addiction market
9.2 Future Opportunities
10. Strategic Recommendations

EU Drug Addiction Market Analysis Segmentation

By Drug Type:

The market share occupied by the Alcohol segment is attributed, high rate of consumption, easy availability, its legalization in most of the countries, and social acceptance of this type of drug, which contributes to the market share occupied by this segment. Its increasing incorporation in various types of gatherings and socialization also contributes to the market share held by this segment.

By Treatment:

The market growth rate witnessed by this segment is attributed to government awareness programs and associated rising awareness about the adverse impact of consumption of drugs, which are resulting in increasing number of individuals willing to take the step to quit the intake of these drugs and joining self-help groups to keep themselves motivated, which is contributing to the increasing popularity and growth rate witnessed by this segment.

By End-User:

The market share held by the Hospital and Clinics segment is attributed to the present situation of delayed detection of the condition because of apprehension on availing the treatment among the patients, which results in serious cases of addiction that requires hospitalization for providing the care user with the needed treatments, contributing to the market share held by this segment.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements